Related references
Note: Only part of the references are listed.Association of cytokines with hepatitis B virus and its antigen
Ming-hui Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B
Kin Seng Liem et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Systematic review with meta-analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance
K. Qiu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Formal comment on: Myhrvold (2016) Dinosaur metabolism and the allometry of maximum growth rate. PLoS ONE; 11(11): e0163205
Eva Maria Griebeler et al.
PLOS ONE (2018)
T cell regulation in HBV-related chronic liver disease
Carlo Ferrari et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t) ide Analogue: A Randomized, Controlled Trial (PEGON)
Heng Chi et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients
Yadong Wang et al.
SCIENTIFIC REPORTS (2017)
NK cell phenotypic and functional shifts coincide with specific clinical phases in the natural history of chronic HBV infection
Rik A. de Groen et al.
ANTIVIRAL RESEARCH (2017)
Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B
G. L. -H. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir
S. B. Willemse et al.
ANTIVIRAL RESEARCH (2016)
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin et al.
GASTROENTEROLOGY (2016)
Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment
Guo-Jun Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Natural Killer Cell Phenotype Modulation and Natural Killer/T-Cell Interplay in Nucleos(t)ide Analogue-Treated Hepatitis e Antigen-Negative Patients With Chronic Hepatitis B
Carolina Boni et al.
HEPATOLOGY (2015)
Adding Pegylated Interferon to Entecavir for Hepatitis B e Antigen-Positive Chronic Hepatitis B: A Multicenter Randomized Trial (ARES Study)
Willem Pieter Brouwer et al.
HEPATOLOGY (2015)
Intrahepatic and Peripheral CXCL10 Expression in Hepatitis C Virus-Infected Patients Treated With Telaprevir, Pegylated Interferon, and Ribavirin
Marija Zeremski et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Reduction of HBV replication prolongs the early immunological response to IFNα therapy
Anthony T. Tan et al.
JOURNAL OF HEPATOLOGY (2014)
Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2014)
Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B
Milan J. Sonneveld et al.
JOURNAL OF HEPATOLOGY (2013)
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
Lorenzo Micco et al.
JOURNAL OF HEPATOLOGY (2013)
Rapid downregulation of programmed death-1 and interferon-γ-inducible protein-10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B
F. -Q. Hou et al.
JOURNAL OF VIRAL HEPATITIS (2013)
High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B
Shi-Wu Ma et al.
JOURNAL OF HEPATOLOGY (2012)
Living in the liver: hepatic infections
Ulrike Protzer et al.
NATURE REVIEWS IMMUNOLOGY (2012)
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C
G. Fattovich et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues
Jerzy Jaroszewicz et al.
ANTIVIRAL THERAPY (2011)
Hepatitis B Virus Limits Response of Human Hepatocytes to Interferon-α in Chimeric Mice
Marc Luetgehetmann et al.
GASTROENTEROLOGY (2011)
Quantitation of Pretreatment Serum Interferon-gamma-Inducible Protein-10 Improves the Predictive Value of an IL28B Gene Polymorphism for Hepatitis C Treatment Response
Jama M. Darling et al.
HEPATOLOGY (2011)
Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B
Eric T. T. L. Tjwa et al.
JOURNAL OF HEPATOLOGY (2011)
Serum Levels of Interleukin-10 and Interleukin-12 Predict Early, Spontaneous Hepatitis B Virus e Antigen Seroconversion
Jia-Feng Wu et al.
GASTROENTEROLOGY (2010)
Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection
Dimitra Peppa et al.
PLOS PATHOGENS (2010)
HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B
Yun-Fan Liaw
HEPATOLOGY INTERNATIONAL (2009)
Intrahepatic Levels of CXCR3-Associated Chemokines Correlate With Liver Inflammation and Fibrosis in Chronic Hepatitis C
Marija Zeremski et al.
HEPATOLOGY (2008)
Infectious disease, the innate immune response, and fibrosis
Alessia Meneghin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
